Agreement between time-domain and spectral-domain optical coherence tomography in the assessment of macular thickness in patients with idiopathic macular telangiectasia type 2

Ophthalmologica

Volumn 230, Issue 3, 2013, Pages 144-150

  Mathew, Raeba ^a   Sivaprasad, Sobha ^a   Florea, Daniela ^a   Leung, Irene ^a   Sallo, Ferenc ^a   Clemons, Traci ^b   Bird, Alan C ^a   Peto, Tunde ^a  

^a MOORFIELDS EYE HOSPITAL   (United Kingdom)

^b EMMES CORPORATION   (United States)

Author keywords

Macular telangiectasia type 2a; Macular thickness; Spectral domain optical coherence tomography; Time domain optical coherence tomography

Indexed keywords

ARTICLE; FOLLOW UP; HUMAN; IDIOPATHIC MACULAR TELANGIECTASIA TYPE 2; MACULAR THICKNESS; MAJOR CLINICAL STUDY; OPTICAL COHERENCE TOMOGRAPHY; OPTICAL COHERENCE TOMOGRAPHY DEVICE; RETINAL TELANGIECTASIA; RETINAL THICKNESS; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY; TIME DOMAIN OPTICAL COHERENCE TOMOGRAPHY;

HUMANS; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; RETINA; RETINAL TELANGIECTASIS; TIME FACTORS; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 84885123011     PISSN: 00303755     EISSN: 14230267     Source Type: Journal    
DOI: 10.1159/000353455     Document Type: Article

References (21)

1. Yannuzzi LA, Bardal AM, Freund KB, Chen KJ, Eandi CM, Blodi B: Idiopathic macular telangiectasia. Arch Ophthalmol 2006; 124: 450-460.
2. Schmitz-Valckenberg S, Ong EE, Rubin GS, et al: Structural and functional changes over time in MacTel patients. Retina 2009; 29: 1314-1320.
3. Ooto S, Hangai M, Takayama K, et al: Highresolution photoreceptor imaging in idiopathic macular telangiectasia type 2 using adaptive optics scanning laser ophthalmoscopy. Invest Ophthalmol Vis Sci 2011; 52: 5541-5550.
4. Kiernan DF, Hariprasad SM, Chin EK, Kiernan CL, Rago J, Mieler WF: Prospective comparison of Cirrus and Stratus optical coherence tomography for quantifying retinal thickness. Am J Ophthalmol 2009; 147: 267-275.
5. Warner CV, Syc SB, Stankiewicz AM, et al: The impact of utilizing different optical coherence tomography devices for clinical purposes and in multiple sclerosis trials. PLoS One 2011; 6:e22947.
6. Srinivasan VJ, Wojtkowski M, Witkin AJ, et al: High-definition and 3-dimensional imaging of macular pathologies with high-speed ultrahigh-resolution optical coherence tomography. Ophthalmology 2006; 113: 2054.
7. Costa RA, Calucci D, Skaf M, et al: Optical coherence tomography 3: automatic delineation of the outer neural retinal boundary and its influence on retinal thickness measurements. Invest Ophthalmol Vis Sci 2004; 45: 2399-2406.
8. Pons ME, Garcia-Valenzuela E: Redefining the limit of the outer retina in optical coherence tomography scans. Ophthalmology 2005; 112: 1079-1085.
9. Spaide RF: Questioning optical coherence tomography. Ophthalmology 2012; 119: 2203-2204.
10. Han IC, Jaffe GJ: Comparison of spectral-and time-domain optical coherence tomography for retinal thickness measurements in healthy and diseased eyes. Am J Ophthalmol 2009; 147: 847-858.
11. Sull AC, Vuong LN, Price LL, et al: Comparison of spectral/Fourier domain optical coherence tomography instruments for assessment of normal macular thickness. Retina 2010; 30: 235-245.
12. Forooghian F, Cukras C, Meyerle CB, Chew EY, Wong WT: Evaluation of time domain and spectral domain optical coherence tomography in the measurement of diabetic macular edema. Invest Ophthalmol Vis Sci 2008; 49: 4290-4296.
13. Hendrickson A, Drucker D: The development of parafoveal and mid-peripheral human retina. Behav Brain Res 1992; 49: 21-31.
14. Geitzenauer W, Kiss CG, Durbin MK, et al: Comparing retinal thickness measurements from Cirrus spectral domain-and Stratus time domain-optical coherence tomography. Retina 2010; 30: 596-606.
15. Kakinoki M, Sawada O, Sawada T, Kawamura H, Ohji M: Comparison of macular thickness between Cirrus HD-OCT and Stratus OCT. Ophthalmic Surg Lasers Imaging 2009; 40: 135-140.
16. Grover S, Murthy RK, Brar VS, Chalam KV: Comparison of retinal thickness in normal eyes using Stratus and Spectralis optical coherence tomography. Invest Ophthalmol Vis Sci 2010; 51: 2644-2647.
17. Leung CK, Cheung CY, Weinreb RN, et al: Comparison of macular thickness measurements between time domain and spectral domain optical coherence tomography. Invest Ophthalmol Vis Sci 2008; 49: 4893-4897.
18. Bland JM, Altman DG: Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;i: 307-310.
19. Wolf-Schnurrbusch UE, Ceklic L, Brinkmann CK, et al: Macular thickness measurements in healthy eyes using six different optical coherence tomography instruments. Invest Ophthalmol Vis Sci 2009; 50: 3432-3437.
20. Giani A, Cigada M, Choudhry N, et al: Reproducibility of retinal thickness measurements on normal and pathologic eyes by different optical coherence tomography instruments. Am J Ophthalmol 2010; 150: 815-824.
21. Ibrahim MA, Sepah YJ, Symons RC, et al: Spectral-and time-domain optical coherence tomography measurements of macular thickness in normal eyes and in eyes with diabetic macular edema. Eye (Lond) 2012; 26: 454-462.